Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-22 Sale |
2024-07-23 4:37 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $53.93 | $269,662 | 15,480 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-28 4:06 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $51.93 | $1,557,940 | 60,480 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-21 7:00 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,525 | $49.26 | $124,382 | 106,722 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 7:51 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $53.81 | $269,053 | 4,045 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-23 Exercise |
2025-02-24 5:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
6,688 | $0 | 51,963 (Direct) |
View |
| 2025-02-23 Tax Withholding |
2025-02-24 5:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
3,601 | $57.75 | 51,963 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-21 6:49 pm |
2026-02-20 2035-02-20 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
43,930 | $0 | 43,930 (Direct) |
View |
| 2025-02-15 Tax Withholding |
2025-02-18 6:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
15,752 | $58.29 | 44,564 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-18 6:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
29,085 | $0 | 44,564 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 6:09 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
46,868 | $0 | 61,190 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $22.5 | 15,480 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 4:37 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $0 | 15,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $22.5 | 60,480 (Direct) |
View |
| 2024-06-26 Exercise |
2024-06-28 4:06 pm |
N/A 2025-07-01 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
30,000 | $0 | 60,480 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:05 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
54,473 | $0 | 54,473 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,601 | $36.1 | 41,653 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
10,422 | $0 | 41,653 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,254 | $0 | 11,913 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
686 | $35.91 | 11,913 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,477 | $35.49 | 10,091 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,502 | $0 | 10,091 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 7:00 pm |
2024-02-16 2033-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
82,377 | $0 | 106,722 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 7:00 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,094 | $0 | 106,722 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 06:25 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
621 | $49.2 | 9,005 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 06:25 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,254 | $0 | 9,005 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-14 5:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
3,892 | $0 | 8,366 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,073 | $48.92 | 8,366 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-17 6:03 pm |
2023-02-16 2032-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
82,688 | $0 | 95,495 (Direct) |
View |
| 2022-02-15 Exercise |
2022-02-17 6:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
1,255 | $0 | 95,495 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 6:03 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
433 | $34.43 | 95,495 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
1,025 | $34.94 | 14,617 (Direct) |
View |
| 2022-02-12 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
506 | $34.2 | 14,617 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
5,148 | $0 | 14,617 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-14 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
427 | $33.64 | 14,617 (Direct) |
View |
Ownership |
2022-02-11 4:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer |
0 | $0 | 123,456 (Direct) |
View |